Patent · US Active

Iridium organometallic complex containing a substituted dibenzo[f,h]quinoxaline and an electronic device having an emitting layer containing the iridium complex

US10167303B2 · kind B2 · utility

0Cited by

2References

13Claims

0Family size

Assignee

UDC IRELAND LIMITED · IE

Inventors

Peter Murer · Oberwil, CH
Stephan Allenbach · Sisseln, CH
Gerhard Wagenblast · Wachenheim, DE
Christian Schildknecht · Schifferstadt, DE
Christian Lennartz · Dublin, IE

Key dates

Filing date	Aug 31, 2016
Grant date	Jan 1, 2019
Priority date	—
Expiry date	Aug 31, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02E10/549
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Iridium organometallic complexes containing a substituted dibenzo[f,h]quinoxaline having the formula are provided. These compounds are useful as orange or red emitting components of a light emitting layer in an electronic device.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.